A detailed history of Envestnet Asset Management Inc transactions in Natera, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 200,306 shares of NTRA stock, worth $33.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
200,306
Previous 187,438 6.87%
Holding current value
$33.5 Million
Previous $20.3 Million 25.43%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$97.75 - $129.67 $1.26 Million - $1.67 Million
12,868 Added 6.87%
200,306 $25.5 Million
Q2 2024

Aug 08, 2024

BUY
$85.28 - $112.6 $183,181 - $241,864
2,148 Added 1.16%
187,438 $20.3 Million
Q1 2024

May 13, 2024

BUY
$59.21 - $92.9 $1.64 Million - $2.57 Million
27,688 Added 17.57%
185,290 $16.9 Million
Q4 2023

Feb 13, 2024

SELL
$37.55 - $62.64 $779,087 - $1.3 Million
-20,748 Reduced 11.63%
157,602 $9.87 Million
Q3 2023

Nov 13, 2023

BUY
$43.4 - $62.52 $3.14 Million - $4.53 Million
72,400 Added 68.33%
178,350 $7.89 Million
Q2 2023

Aug 04, 2023

BUY
$47.08 - $55.16 $311,669 - $365,159
6,620 Added 6.66%
105,950 $5.16 Million
Q1 2023

May 11, 2023

SELL
$36.57 - $58.29 $126,824 - $202,149
-3,468 Reduced 3.37%
99,330 $5.51 Million
Q4 2022

Feb 07, 2023

BUY
$34.17 - $47.91 $694,573 - $973,866
20,327 Added 24.65%
102,798 $4.13 Million
Q3 2022

Nov 10, 2022

BUY
$36.93 - $56.68 $754,590 - $1.16 Million
20,433 Added 32.94%
82,471 $3.61 Million
Q2 2022

Aug 03, 2022

SELL
$28.13 - $44.54 $140,818 - $222,967
-5,006 Reduced 7.47%
62,038 $2.2 Million
Q1 2022

May 04, 2022

SELL
$30.32 - $91.33 $2.07 Million - $6.25 Million
-68,418 Reduced 50.51%
67,044 $2.73 Million
Q4 2021

Feb 04, 2022

BUY
$86.26 - $119.0 $841,035 - $1.16 Million
9,750 Added 7.76%
135,462 $12.7 Million
Q3 2021

Oct 07, 2021

BUY
$100.17 - $126.36 $1.79 Million - $2.26 Million
17,891 Added 16.59%
125,712 $14 Million
Q2 2021

Aug 04, 2021

BUY
$86.05 - $119.72 $225,881 - $314,265
2,625 Added 2.5%
107,821 $12.2 Million
Q1 2021

May 04, 2021

BUY
$91.47 - $124.36 $5.95 Million - $8.09 Million
65,050 Added 162.03%
105,196 $10.7 Million
Q4 2020

Feb 02, 2021

BUY
$66.66 - $111.74 $114,855 - $192,528
1,723 Added 4.48%
40,146 $4 Million
Q3 2020

Oct 09, 2020

BUY
$45.89 - $72.67 $467,619 - $740,507
10,190 Added 36.09%
38,423 $2.78 Million
Q2 2020

Jul 08, 2020

BUY
$26.36 - $49.86 $62,552 - $118,317
2,373 Added 9.18%
28,233 $1.41 Million
Q1 2020

Apr 23, 2020

SELL
$17.27 - $40.17 $3,367 - $7,833
-195 Reduced 0.75%
25,860 $772,000
Q4 2019

Feb 11, 2020

BUY
$32.1 - $40.4 $55,500 - $69,851
1,729 Added 7.11%
26,055 $878,000
Q3 2019

Oct 17, 2019

BUY
$25.38 - $34.89 $270,677 - $372,101
10,665 Added 78.07%
24,326 $798,000
Q2 2019

Aug 02, 2019

BUY
$17.75 - $27.58 $242,482 - $376,770
13,661 New
13,661 $377,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.